Prosecution Insights
Last updated: August 06, 2026

Haukaas Fortius Pllc

29 pending office actions • 18 clients • 29 examiners • 22 art units • 0 of 29 (0%) have an AI response strategy ready

Quality Metrics (n=817 apps, methodology: how we score firms)

86.0%
Allowance Rate
n=817
+0.92σ
Allowance Rate (norm)
n=817
3.3
OAs to Allowance
n=382
-0.30σ
OAs to Allow (norm)
n=382
954 days
Time to Allowance
n=382
+13.6pp
Interview Lift
n=817
20.0%
RCE Rate
n=817
0.0%
Appeal Rate
n=817

Rejection Performance (% of received rejections ultimately overcome)

77.5%
§101 Overcome
n=40
73.8%
§102 Overcome
n=202
74.7%
§103 Overcome
n=289
76.4%
§112 Overcome
n=259

Specialization & Scale

A61K, A61P, C07D
Top CPC Subclasses
33%
Top-3 CPC Share
n=817
2
Practitioners
n=817
408.5
Apps / Practitioner
n=817

Portfolio Summary

29
Total Pending OAs
21
Non-Final OAs
7
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
4
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (4)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

21
Hard (72%)
7
Medium (24%)
1
Easy (3%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (7%)
§103 only4 (14%)
§112 only1 (3%)
Double-patenting + other3 (10%)
Multi-statute (no §101)19 (66%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

19
Life Sciences
66% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
7% of docket
3
Mechanical / Eng
10% of docket
5
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

290 h
Manual time on pending OAs
58 h
Time saved (low, 20%)
102 h
Time saved (mid, 35%)
2.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SUN, CAITLYN MINGYUN 1 63.3% +11.4%
WEISBERG, AMY REGINA 1 52.5% +25.7%
TRAN, LIEN THUY 1 28.2% +26.8%
WHITE, DAWANNA SHAR-DAY 1 62.8% +19.6%
KIM, BOBBY YEONJIN 1 76.7% +21.6%
POTHEN, FEBA 1 80.9% +11.3%
POLLOCK, AUSTIN M 1 51.7% +36.5%
RITCHIE, HADEN MATTHEW 1 73.4% +33.8%
KEYWORTH, PETER 1 58.3% +24.0%
RILEY, JEZIA 1 82.9% +7.3%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18503951 CHEMICAL TOOLS FOR RNA 3D STRUCTURE DETERMINATION IN VIVO RILEY, JEZIA

Hard Cases (21)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18551559 SENSING SYSTEM TIMILSINA, SHARAD 77d overdue
17771896 COMPOUNDS AND METHODS FOR POTENTIATING COLISTIN ACTIVITY HIRAKIS, SOPHIA P 44d overdue
18300640 RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING ZINGARELLI, SANDRA 10d overdue
17291169 PHARMACEUTICAL COMPOSITION WHICH COMPRISES THE COMBINATION OF A SELECTIVE INHIBITOR OF CYCLOOXYGENASE 2 AND A CARBAMATE DERIVED FROM GUAIFENESIN FOR TREATING PAIN, INFLAMMATION AND MUSCULAR CONTRACTION BAEK, BONG-SOOK 2d overdue
18633985 PHOTOIONIZATION DETECTOR POTHEN, FEBA 13d
17377159 OCULAR COMPOSITIONS AND METHODS REYNOLDS, FRED H 14d
18261373 ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE KIM, SEONG JONG 21d
18914910 TUNABLE ELECTROOSMOTIC FLOW POLYMER COATED CAPILLARY SUN, CAITLYN MINGYUN

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18633985 PHOTOIONIZATION DETECTOR POTHEN, FEBA 13d
18914910 TUNABLE ELECTROOSMOTIC FLOW POLYMER COATED CAPILLARY SUN, CAITLYN MINGYUN
18842176 CRANIAL FIXATION DEVICE FOR DECOMPRESSIVE / AUGMENTATIVE CRANIECTOMY WEISBERG, AMY REGINA
18838803 COMPOSITION COMPRISING AN OLEOGEL AND A METHOD FOR PRODUCING A COMPOSITION COMPRISING AN OLEOGEL TRAN, LIEN THUY
18834350 IMIDAZOTETRAZINE COMPOUNDS AND TREATMENT OF TMZ-RESISTANT CANCERS WHITE, DAWANNA SHAR-DAY
18708404 BAMBOO ELEMENTS AS LOAD-BEARING COMPONENTS AND T-BEAM ELEMENT AS CEILING ELEMENT, AND METHOD FOR PRODUCING A BAMBOO BLANK KIM, BOBBY YEONJIN
18683654 METHOD AND APPARATUS FOR IN SITU DEBINDING AND SINTERING OF FILAMENT OR PASTE EXTRUSION ADDITIVE MANUFACTURED METAL OR CERAMIC PARTS POLLOCK, AUSTIN M
18576658 METHOD AND APPARATUS FOR A STEADY STATE INTRAMUSCULAR INFUSION OF SEROTONERGIC DRUGS RITCHIE, HADEN MATTHEW

Client Portfolio (18 clients)

Top Art Units

Art UnitApps
16932
16532
37251
28581
17381
37831
17771
16811
28571
16361

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18914910 TUNABLE ELECTROOSMOTIC FLOW POLYMER COATED CAPILLARY UNIVERSITY OF NOTRE DAME DU LAC SUN, CAITLYN MINGYUN §103§112 Non-Final OA Pending Oct 14, 2024
18842176 CRANIAL FIXATION DEVICE FOR DECOMPRESSIVE / AUGMENTATIVE CRANIECTOMY Ntplast S.r.l. WEISBERG, AMY REGINA §102§103§112Other Non-Final OA Pending Aug 28, 2024
18838803 COMPOSITION COMPRISING AN OLEOGEL AND A METHOD FOR PRODUCING A COMPOSITION COMPRISING AN OLEOGEL Perfat Technologies OY TRAN, LIEN THUY §101§102§103§112 Non-Final OA Pending Aug 15, 2024
18834350 IMIDAZOTETRAZINE COMPOUNDS AND TREATMENT OF TMZ-RESISTANT CANCERS The Board Of Trustees Of The University Of Illinois WHITE, DAWANNA SHAR-DAY §102§103DP Non-Final OA Pending Jul 30, 2024
18708404 BAMBOO ELEMENTS AS LOAD-BEARING COMPONENTS AND T-BEAM ELEMENT AS CEILING ELEMENT, AND METHOD FOR PRODUCING A BAMBOO BLANK Clb Entwicklungsgesellschaft Mbh KIM, BOBBY YEONJIN 3725 §102§103§112 Non-Final OA Pending May 08, 2024
18633985 PHOTOIONIZATION DETECTOR Alphasense Limited POTHEN, FEBA 2858 §102§103§112 Non-Final OA 13d Pending Apr 12, 2024
18683654 METHOD AND APPARATUS FOR IN SITU DEBINDING AND SINTERING OF FILAMENT OR PASTE EXTRUSION ADDITIVE MANUFACTURED METAL OR CERAMIC PARTS Technische Universität Berlin POLLOCK, AUSTIN M 1738 §102§103§112 Non-Final OA Pending Feb 14, 2024
18576658 METHOD AND APPARATUS FOR A STEADY STATE INTRAMUSCULAR INFUSION OF SEROTONERGIC DRUGS Psoulmed, LLC RITCHIE, HADEN MATTHEW 3783 §103§112 Non-Final OA Pending Jan 04, 2024
18568609 ELECTROCHEMICALLY-REGENERATED ION EXCHANGE USING REDOX-POLYMERS The Board Of Trustees Of The University Of Illinois KEYWORTH, PETER 1777 §102§103 Non-Final OA Pending Dec 08, 2023
18503951 CHEMICAL TOOLS FOR RNA 3D STRUCTURE DETERMINATION IN VIVO Stichting Radboud Universiteit RILEY, JEZIA 1681 §112 Non-Final OA Pending Nov 07, 2023
18493223 THERAPEUTIC POLY-ADP-RIBOSE POLYMER-GCSF CONJUGATES UNIVERSITY OF SOUTHERN CALIFORNIA LAU, JONATHAN S 1693 §102§103§112 Non-Final OA Pending Oct 24, 2023
18382796 REDOX-RESPONSIVE HALOGEN BONDING POLYMERS FOR SELECTIVE ELECTROCHEMICAL SEPARATION The Board Of Trustees Of The University Of Illinois JEBUTU, MOFOLUWASO SIMILOLUWA §102§103§112 Non-Final OA Pending Oct 23, 2023
18551559 SENSING SYSTEM Alphasense Limited TIMILSINA, SHARAD 2857 §102§103 Non-Final OA 77d overdue Pending Sep 20, 2023
18550777 CANCER THERAPY National University Corporation Kobe University CHONG, KIMBERLY 1636 §102§112 Non-Final OA Pending Sep 15, 2023
18546472 CELL-FREE DNA METHYLATION TEST UNIVERSITY OF SOUTHERN CALIFORNIA JONES, CHRISTINE MICHELLE 1682 §101§102§103§112 Non-Final OA Pending Aug 15, 2023
18263582 ENZYME INHIBITORS AND VIRAL INFECTION THERAPY UNIVERSITY OF SOUTHERN CALIFORNIA VAJDA, KRISTIN ANN 1622 §102§112 Final Rejection Pending Jul 31, 2023
18261373 ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE The Board Of Trustees Of The University Of Illinois KIM, SEONG JONG 1621 §102§103 Final Rejection 21d Pending Jul 13, 2023
18334732 MACROCYCLIC PEPTIDES UNIVERSITY OF NOTRE DAME DU LAC HA, JULIE 1654 §102§112DP Non-Final OA Pending Jun 14, 2023
18253857 SYNTHESIS OF [18F]-LABELED THYMIDINE ANALOGUES UNIVERSITY OF SOUTHERN CALIFORNIA BAEK, JONGHWAN NMN 1618 §103DP Final Rejection 15d Pending May 22, 2023
18320485 NANO-HYPERBARIC WOUND HEALING THERAPEUTIC Revive Biotechnology, Inc. YU, HONG 1614 §103§112 Final Rejection Pending May 19, 2023
18300640 RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING Iowa State University Research Foundation, Inc. ZINGARELLI, SANDRA 1653 §103§112 Non-Final OA 10d overdue Pending Apr 14, 2023
17996452 CYCLODEXTRIN BASED ANTI-MICROBIAL THERAPY UNIVERSITY OF SOUTHERN CALIFORNIA CHO, DAVID H 1693 §103 Non-Final OA Pending Oct 18, 2022
17773672 EAR-WEARABLE DEVICE AND OPERATION THEREOF Nt Labs Pvt Ltd. CHA, CASEY GEORGE 3794 §103 Non-Final OA Pending May 02, 2022
17771896 COMPOUNDS AND METHODS FOR POTENTIATING COLISTIN ACTIVITY UNIVERSITY OF NOTRE DAME DU LAC HIRAKIS, SOPHIA P 1623 §102§103 Final Rejection 44d overdue Pending Apr 26, 2022
17626888 SYNERGISTIC COMBINATION OF S-KETOROLAC AND PREGABALIN IN A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF NEUROPATHIC PAIN Carlos Amezcua Amezcua JUSTICE, GINA CHIEUN YU 1617 §103§112 Non-Final OA Pending Jan 13, 2022
17429299 MATERIALS AND METHODS FOR THE PREPARATION OF BACTERIAL CAPSULAR POLYSACCHARIDES The Regents of the University of California IANNUZO, NATALIE NMN 1653 §103 Non-Final OA 23d overdue Pending Aug 06, 2021
17377159 OCULAR COMPOSITIONS AND METHODS Silk Technologies, Ltd. REYNOLDS, FRED H 1658 §103§112Other Final Rejection 14d Pending Jul 15, 2021
17291169 PHARMACEUTICAL COMPOSITION WHICH COMPRISES THE COMBINATION OF A SELECTIVE INHIBITOR OF CYCLOOXYGENASE 2 AND A CARBAMATE DERIVED FROM GUAIFENESIN FOR TREATING PAIN, INFLAMMATION AND MUSCULAR CONTRACTION Carlos Amezcua Amezcua BAEK, BONG-SOOK 1611 §103§112 Final Rejection 2d overdue Pending May 04, 2021
16094791 ISOLATION OF PLANT EXTRACTS Plant Extraction, LLC (A Georgia Limited Liability Company) BOECKELMAN, JACOB A 1655 §103 Non-Final OA 53d Pending Oct 18, 2018

Managing Haukaas Fortius Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month